The U.S. Food and Drug Administration (FDA) is weighing a change that could make warning labels on dietary supplements appear ...

Based Probiotic Category Ahead of 2026 Weight-Loss Season - Ingredient Research, Regulatory Context, and Evidence Gaps ...

Researchers at Osaka Metropolitan University have discovered a practical way to detect and fix common labeling errors in ...

BeOne Medicines ($ONC) announced an update on their ongoing clinical study. BeOne Medicines is running an early-stage trial to test a new cancer ...

The Best Weight Loss Supplements for Women This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: The best ...

Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every ...

Long-term data published in JAMA Neurology further illustrate the effects of Biogen’s QALSODY on function, strength, and ...

Ceralasertib is an oral selective inhibitor of the ATR kinase, an important DNA-repairing protein in tumor cells.

Explore a probability-driven options framework that bypasses valuation logic to identify favorable risk-reward setups in these large-cap names.

Geron stock struggles as RYTELO faces niche demand, high discontinuation, and major cost cuts. Click here to read my most ...

AMD Phase 3 timing, Otsuka funding to 2028, and mixed 4D-710 data with financial risk. See why FDMT stock is a hold.

When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses ...